Understanding the Tagrisso Prescribing Information: What You Need to Know
If you or a loved one has been diagnosed with non-small cell lung cancer, your doctor may recommend Tagrisso. Tagrisso is a prescription medication that is used to treat a specific type of non-small cell lung cancer. As with any medication, it is important to understand the prescribing information for Tagrisso. In this article, we will discuss the essential information you need to know about Tagrisso prescribing.
What is Tagrisso?
Tagrisso (osimertinib) is a medication used to treat non-small cell lung cancer (NSCLC) with a specific mutation called EGFR T790M. This mutation occurs in about half of the patients who develop NSCLC. Tagrisso works by blocking proteins that help cancer cells grow and divide. It is available in tablet form and is taken once a day.
How is Tagrisso Prescribed?
Tagrisso is a prescription medication that can only be prescribed by a doctor. Before prescribing Tagrisso, the doctor will need to determine if the patient has the specific mutation that the medication is intended to treat. This is done through a special test called the cobas® EGFR Mutation Test v2, which is FDA-approved.
The recommended dose of Tagrisso is 80 mg taken once daily orally, with or without food. Patients should take Tagrisso at the same time each day. The medication should be swallowed whole and should not be chewed, crushed, or broken.
Who Can Take Tagrisso?
Tagrisso is only intended for patients who have non-small cell lung cancer with a specific mutation called EGFR T790M. This means that patients who do not have this mutation should not take Tagrisso. Additionally, Tagrisso is not recommended for patients who are pregnant or breastfeeding.
What are the Side Effects of Tagrisso?
Like any medication, Tagrisso may cause side effects. Some of the most common side effects of Tagrisso may include:
– Diarrhea
– Rash
– Dry skin
– Nail problems
– Fatigue
– Decreased appetite
– Nausea
– Vomiting
– Sore mouth and throat
– Itching
Not everyone who takes Tagrisso will experience side effects. However, if any side effects are experienced, it is important to inform a doctor.
Conclusion
If you or a loved one has been diagnosed with non-small cell lung cancer with the EGFR T790M mutation, your doctor may recommend Tagrisso. Understanding the prescribing information of Tagrisso is important to ensure that you take the medication safely and effectively. It is always recommended to talk to your doctor about any questions or concerns you may have before starting a new medication.
(Note: Do you have knowledge or insights to share? Unlock new opportunities and expand your reach by joining our authors team. Click Registration to join us and share your expertise with our readers.)
Speech tips:
Please note that any statements involving politics will not be approved.